linagliptin and metformin hydrochloride

Generic: linagliptin and metformin hydrochloride

Labeler: novadoz pharmaceuticals llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name linagliptin and metformin hydrochloride
Generic Name linagliptin and metformin hydrochloride
Labeler novadoz pharmaceuticals llc
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

linagliptin 2.5 mg/1, metformin hydrochloride 500 mg/1

Manufacturer
Novadoz Pharmaceuticals LLC

Identifiers & Regulatory

Product NDC 72205-407
Product ID 72205-407_5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208459
Listing Expiration 2026-12-31
Marketing Start 2025-11-03

Pharmacologic Class

Established (EPC)
dipeptidyl peptidase 4 inhibitor [epc]
Mechanism of Action
dipeptidyl peptidase 4 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72205407
Hyphenated Format 72205-407

Supplemental Identifiers

RxCUI
1243020 1243027 1243034
UPC
0372205408029 0372205407015 0372205409019 0372205407022 0372205409026 0372205408012
UNII
3X29ZEJ4R2 786Z46389E
NUI
N0000175912 N0000175913

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name linagliptin and metformin hydrochloride (source: ndc)
Generic Name linagliptin and metformin hydrochloride (source: ndc)
Application Number ANDA208459 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/1
  • 500 mg/1
source: ndc
Packaging
  • 60 TABLET, FILM COATED in 1 BOTTLE (72205-407-01)
  • 180 TABLET, FILM COATED in 1 BOTTLE (72205-407-02)
source: ndc

Packages (2)

Ingredients (2)

linagliptin (2.5 mg/1) metformin hydrochloride (500 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb", "openfda": {"nui": ["N0000175912", "N0000175913"], "upc": ["0372205408029", "0372205407015", "0372205409019", "0372205407022", "0372205409026", "0372205408012"], "unii": ["3X29ZEJ4R2", "786Z46389E"], "rxcui": ["1243020", "1243027", "1243034"], "spl_set_id": ["5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb"], "pharm_class_epc": ["Dipeptidyl Peptidase 4 Inhibitor [EPC]"], "pharm_class_moa": ["Dipeptidyl Peptidase 4 Inhibitors [MoA]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (72205-407-01)", "package_ndc": "72205-407-01", "marketing_start_date": "20251104"}, {"sample": false, "description": "180 TABLET, FILM COATED in 1 BOTTLE (72205-407-02)", "package_ndc": "72205-407-02", "marketing_start_date": "20251104"}], "brand_name": "Linagliptin and metformin hydrochloride", "product_id": "72205-407_5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Biguanide [EPC]", "Biguanides [CS]", "Dipeptidyl Peptidase 4 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]"], "product_ndc": "72205-407", "generic_name": "Linagliptin and metformin hydrochloride", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Linagliptin and metformin hydrochloride", "active_ingredients": [{"name": "LINAGLIPTIN", "strength": "2.5 mg/1"}, {"name": "METFORMIN HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA208459", "marketing_category": "ANDA", "marketing_start_date": "20251103", "listing_expiration_date": "20261231"}